Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Central venous access catheters

C L Shapiro1

  • 1Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Surgical Oncology Clinics of North America
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Central venous catheters are vital for adult and pediatric cancer patients, offering essential treatment access. This review covers their uses and significant complications.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bigger isn't always better: the ESMO dose de-intensification guideline framework.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.

European journal of cancer care·2015
Same author

Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo.

Breast cancer research and treatment·2011
Same author

Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809.

European journal of cancer (Oxford, England : 1990)·2011
Same author

Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?

Breast cancer research and treatment·2008
Same journal

Small Incisions, Big Impact-Robotic Surgery Is Revolutionizing Cancer Care.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Cancer.

Surgical oncology clinics of North America·2026
Same journal

TeleSurgery: The Present and the Future for Minimally Invasive and Robotic Surgery.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Rectal Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive/Robotic Surgery for Colon Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery in Liver Transplantation.

Surgical oncology clinics of North America·2026
See all related articles

Area of Science:

  • Medical Devices
  • Oncology
  • Vascular Access

Background:

  • Central venous catheters (CVCs) have been used for approximately 20 years.
  • These devices are crucial in managing adult and pediatric cancer patients.

Purpose of the Study:

  • To review the indications for using CVCs in oncology.
  • To discuss the major complications associated with CVCs.

Main Methods:

  • Literature review of central venous catheter use in oncology.
  • Discussion of clinical applications and adverse events.

Main Results:

  • CVCs are indispensable for cancer patient treatment.
  • Key indications and complications are identified.

Conclusions:

  • Central venous catheters are essential in modern oncology care.
  • Understanding indications and complications is vital for patient safety.